Background: Hypertension and Chronic Kidney Disease (CKD) are interconnected conditions, with the activation of the transcription factor NF-κB playing a crucial role. Sildenafil used for erectile dysfunction and pulmonary hypertension, may exhibit anti-inflammatory effects by interacting and modulating the structure of NF-κB. Methods: We employed various computational techniques to explore the interaction between sildenafil and NF-κB, including molecular docking, molecular dynamics (MD) simulations, elastic network models, statistical potentials, and volumetric analyses of internal cavities. Results: Sildenafil induces conformational changes in NF-κB, potentially reducing its activity. Molecular docking showed sildenafil’s inhibitory potency is comparable to known anti-inflammatory compounds like resveratrol. MD simulations indicated that sildenafil destabilizes NF-κB’s structure, which may impact its biological function. Experimental validation was conducted using biopsies from hypertensive and kidney-damaged rat models, treated and untreated with sildenafil. Histological and immunoperoxidase analyses assessed cellular infiltration, kidney damage, and NF-κB expression, demonstrated that sildenafil treatment significantly reduced cellular infiltration, kidney damage, and NF-κB expression, confirming its anti-inflammatory properties. Conclusion: sildenafil’s potential to modulate NF-κB activity, offering a promising therapeutic strategy for managing hypertension and CKD. These preliminary findings suggest that sildenafil could be repurposed to provide comprehensive treatment for these conditions, leveraging its molecular and biochemical interactions with NF-κB.
Co-transcriptional splicing and protein self-assembly are governed by coupled kinetic and thermodynamic constraints, such that modest changes in exon processing can propagate into substantial shifts in isoform-dependent mesoscale behavior. Here, we develop a cross-scale physical framework to examine whether transcription-associated kinetic pressure could differentially bias CPEB4 microexon selection and thereby reshape downstream isoform behavior. Using a simplified transcriptional kinetic model, we define an acetylation-associated high-throughput regime as a coarse-grained proxy for reduced time available for co-transcriptional exon recognition. Comparative sequence and structural analyses identify microexon 4 (me4) as less robust than microexon 3 (me3), with weaker cis-regulatory support and lower thermodynamic stability, consistent with greater susceptibility to omission under kinetically constrained conditions. A reduced probabilistic splicing framework accordingly predicts a directional bias against me4, superimposed on a basal transcript landscape in which the full-length isoform remains present. As a complementary downstream analysis, scaled-particle-theory calculations indicate that representative Δ4-enriched scenarios thermodynamically favor homotypic self-association under macromolecular crowding, suggesting a plausible physical amplification route for modest splicing bias. Orthogonal measurements in a yeast perturbation system identify oxidative and spectroscopic signatures compatible with strong butyrate-associated physicochemical stress, but these are interpreted as perturbation readouts rather than direct measurements of neuronal histone acetylation or splicing. Together, these results define a testable cross-scale framework linking transcription-associated kinetic constraints, directional microexon susceptibility, and crowding-dependent remodeling of the CPEB4 isoform assembly landscape.